Skip to main content

ROYAL BANK OF CANADA

Bank

Position in NKTR — Nektar Therapeutics

CIK 1000275 TORONTO, A6

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$568,042
-$596,179 QoQ
Shares Held
8,137
-49.7% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 240 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
0
PutValue
$353,430
PutShares
1,320

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. NKTR ranks #74 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $568,042 8,137
2026-03-31 $1,164,221 16,181
2025-12-31 $296,170 7,005
2025-09-30 $2,237,363 39,321
2025-06-30 $459,356 17,777
2025-03-31 $9,085 13,363
2024-12-31 $26,696 28,707
2024-09-30 $24,285 18,682
2024-06-30 $21,243 17,132
2024-03-31 $316 340
2023-12-31 $414 741
2023-09-30 $60 100
2023-06-30 $216 374
2023-03-31 $8,640 12,344
2022-12-31 $80,684 35,702
2022-09-30 $49,964 15,614
2022-06-30 $31,835 8,378
2022-03-31 $75,010 13,917
2021-12-31 $54,390 4,026
2021-09-30 $289,639 16,127
2021-06-30 $241,730 14,087
2021-03-31 $110,180 5,509
2020-12-31 $280,993 16,529
2020-09-30 $203,725 12,280
2020-06-30 $381,351 16,466
2020-03-31 $579,071 32,441
2020-03-31 $353,430 19,800